Vintage-Ip
Vintage Investment Partners, founded in 2003, focuses on Venture Capital investments with a significant presence in the U.S., Europe, and Israel. The firm operates with a 'blue collar' investor approach, aiming to be a trusted partner that provides invaluable insights and facilitates relevant opportunities and connections for its portfolio companies. Their strategy involves leveraging a proprietary database of over 29,500 investors and partners. Vintage employs a multi-pronged investment strategy involving Fund investments (investing in leading and emerging venture funds), Secondary investments (acquiring limited partnership positions and shares in private tech companies), and Growth investments (co-investing in growth rounds alongside their fund partners). This diversified approach allows them to capture value across different stages of the venture capital lifecycle and to support promising companies through various liquidity events. The firm emphasizes creating lasting value by partnering with visionary leaders and deploying expertise in a meaningful way. They strive to make connections to help both startups and corporates, utilizing their Value+ program to maximize these interactions. Vintage's investments span across the U.S., Europe, Israel, Canada, and other markets, reflecting a broad geographic scope.
Volta Ventures
Volta Ventures invests in ambitious B2B SaaS companies in the Benelux region. They focus on early-stage venture capital, specifically seed and early-stage rounds. They aim to support innovative startups building scalable solutions for business customers. Their investment range is between €100k and €1M, with substantial follow-on potential. They provide support and belief in entrepreneurs to accelerate their growth, offering strategic support. They look for companies with strong product-market fit and potential for rapid scaling. Volta Ventures sees themselves as a long-term partner for their portfolio companies, offering guidance and resources to help them succeed. They actively seek out tools to enhance their own operations, indicating a data-driven approach to investing.
WP2 Investments
WP2 Investments focuses on investing in unique companies and scaling their businesses. Their investment strategy centers around three main pillars: fintech, impact/tech/AI, and green energy. They aim to support companies that are creating innovative solutions and have a positive impact on the world. WP2 Investments seeks to build partnerships with local entities and contributors adhering to RED II directive to support transformational energy projects at both local and national levels. They actively engage with their portfolio companies, highlighting their stories and achievements through blog posts and news articles. The firm is particularly interested in technologies that can drive efficiency, automation, and transparency across various industries.
Wix Capital
Wix Ventures invests in early-stage founders who are product-driven, design-minded and share a long-term vision. They aim to back innovators pushing the boundaries of technology and building a greater web. Their philosophy centers around empowering visionaries, providing support from the pre-seed and seed rounds, offering smart money with real impact (leveraging Wix's experience, know-how, go-to-market expertise and global reach), fostering a product-driven DNA, building a community for collaboration, and investing alongside global powerhouses. Wix Ventures goes beyond just providing capital, actively helping portfolio companies grow by offering access to a global community of Wix users, a founders network, and knowledge from their world-class experts. They emphasize rolling up their sleeves and helping build, rather than just investing. They have an advisory program where founders are connected with advisors to refine product strategy, user experience, growth opportunities, and explore new possibilities. Through sessions, workshops, and deep dives, they aim to help companies move faster and make informed decisions. The Founders Guild, inspired by Wix's organizational structure, empowers founders through peer review, curated content, and talks with industry leaders. The Wix ecosystem itself serves as a live sandbox with millions of actively engaged users, offering opportunities for idea validation, feedback at scale, and adaptation.
YZR Capital
YZR Capital is a venture capital firm focused on investing in European healthcare pioneers. Their mission is to back ambitious entrepreneurs tackling complex challenges in global healthcare. They combine deep expertise with fast execution, providing functional and healthcare-specific know-how to their portfolio companies from day one. The firm aims to help build global champions with lasting impact by partnering with European founders who are shaping the future of global healthcare. They invest in category-defining companies across Europe, focusing on companies that are improving patient care, increasing provider efficiencies, and innovating value chains within healthcare. They are particularly interested in teams solving large problems with scalable, tech-enabled solutions. YZR Capital's investment approach appears to be hands-on, offering functional and healthcare-specific support to help their portfolio companies scale and succeed. This suggests a value-add approach beyond just providing capital, which includes operational guidance and industry-specific expertise.
YZR Capital GmbH
YZR Capital focuses on investing in European HealthTech companies, from pre-seed to Series B, that are improving patient care, increasing provider efficiencies, and innovating value chains within healthcare. They aim to back ambitious entrepreneurs tackling complex challenges in global healthcare, combining deep expertise with fast execution to help build global champions with lasting impact. The firm emphasizes a hands-on, collaborative approach, leveraging their sector expertise to accelerate growth and support the founder's vision, building strong personal relationships with a shared ambition, and the freedom to innovate. They focus on quality over quantity, backing the right founders at the right time, and scaling them into market leaders across Europe. YZR Capital believes Europe offers an unmatched mix of world-class talent, deep tech expertise, and rising healthcare innovation potential. They aim to fill a critical knowledge gap and deploy capital when others paused, positioning themselves as a catalyst for this fast-growing ecosystem. They seek to partner with founders who are making healthcare more efficient, transparent, and accessible, building solutions that shape a healthier future. Their investment approach is centered around supporting founders who are building category-defining companies with scalable, tech-enabled solutions. They actively support their portfolio companies with functional and healthcare-specific know-how from day one. They aim to identify and scale companies that can address the growing challenges within healthcare such as a shortage of healthcare workers and the increasing number of people living with chronic diseases.
ZGI Capital
ZGI Capital provides development financing to companies that have established themselves in their home market and are currently exploring new export markets, increasing capacity, developing new business lines, improving company profitability, or automating processes. They focus on understanding a company's past operations, capital expenditure plans, and the rationale for future growth before making investment decisions. ZGI Capital has experience in various sectors, including metalworking, food, woodworking, logistics, IT, engineering, retail, and service exports. As long-term investors, they collaborate closely with entrepreneurs, leveraging their knowledge and contacts to promote company growth and value appreciation. They offer expertise in areas such as export market development, business model refinement, and negotiations with strategic investors.
Zabolis Partners
Zabolis Partners focuses on creating wealth and fostering change through investments in real estate and private equity. Their portfolio includes sustainable urban developments, educational technology, and innovative sensor technologies, emphasizing high-quality, impactful projects that align with modern urban living principles and technological advancements.
another.vc
another.vc focuses on founders who embrace a different way of thinking, prioritizing the people behind the companies rather than rigid investment theses. Recognizing that products and ideas often evolve in the early stages, the firm places a strong emphasis on the founders' capabilities and adaptability. Their investment approach involves fast decision-making, prioritizing conversations over formal pitches. They aim to provide an initial investment of €100k.
aws Gründerfonds
aws Gründerfonds (Austrian Wirtschaftsservice Seed Fund) focuses on investing in companies with growth-oriented technology and global ambitions. They aim to shape the future by partnering with visionary founders, providing venture capital to support their growth. The fund provides long-term support to outstanding founders.
b.value AG
b.value AG is a venture capital firm focused on investing in DeepTech startups that combine exceptional founders and disruptive technologies to create solutions for a sustainable future. They aim to build a portfolio of fast-growing companies that define the future of production processes and markets, bridging the gap between R&D and global markets. Their strategy is based on identifying and supporting companies with talented founders, scalable business models, and disruptive, protected technologies. The firm specializes in companies operating in the European D-A-CH region (Germany, Austria, Switzerland), particularly those in the pre-seed and seed stages. b.value acquires minority stakes, co-investing with other investors to minimize risk and pool resources. This collaborative approach enables them to foster the success and growth of promising companies. b.value emphasizes its deep technology expertise and operational experience in building and managing biotech and high-tech companies. They aim to offer strategic and financial support, as well as access to a comprehensive network of industry experts, scientists, investors, policymakers, and thought leaders to assist in scaling their portfolio companies. The firm believes that sustainable processes and products are fundamental for the future. Their focus lies on biotechnology (including precision fermentation, sustainable chemicals, food/feed, life science methods) and advanced materials, sectors they view as having above-average growth and innovation potential.
b2venture (btov)
b2venture is an early-stage European venture capital firm that leverages a strong community of angel investors with expertise spanning both tech and industry. This network allows them to bring unique expertise, entrepreneurial experience, and hands-on support to their portfolio companies. They aim to back unique, maverick, and outlier founders. They see themselves as partners for the long term and support companies at the earliest stages with dedication and expertise. b2venture invests primarily in the pre-seed and seed stages, but also has the ability to invest in later stages through its Direct Investments track. They aim to shape the future by investing in the best ideas and brightest minds, helping them to take flight. The firm's website emphasizes the importance of the investment team as strong allies to their portfolio companies. They believe that entrepreneurs are hiring partners, not just raising capital. The site presents the team as deeply experienced, unwavering in their dedication, and uniquely expert, highlighting their role in helping their portfolio companies fly.
eCapital
eCAPITAL is an entrepreneur-led venture capital investor that focuses on early- and growth-stage deep-tech companies with a positive impact on society. They believe that technology is key for solving some of today’s largest problems and improving the way people work and live. The firm supports visionaries who can build this technology, understands their challenges and ambitions, and helps them form great teams and build extraordinary companies. eCAPITAL aims to build European deep-tech teams into global hidden champions and position them so strategic buyers with access to international capital markets step. They seek to partner with founders who have bold ideas and innovative technologies, supporting them in every pivotal moment with strategic support and access to an international network. The firm focuses on companies that are decarbonizing lives and driving the green energy transition, building secure data ecosystems, and turning data into business insights. eCAPITAL emphasizes the growing strategic importance of areas such as mobile security and cybersecurity, especially as critical digital touchpoints are treated as infrastructure.
eCapital Entrepreneurial Partners
eCAPITAL is an entrepreneur-led venture capital firm focused on early- to growth-stage deep-tech companies with a positive impact on society. They believe that technology is key to solving some of today's largest problems and improving the way people work and live. The firm supports visionary founders in building extraordinary companies and bringing us closer to a future that benefits everyone. eCAPITAL targets companies with groundbreaking innovations in software & information technology, cybersecurity, industry 4.0, new materials, and cleantech, with a specific emphasis on companies driving the green energy transition and securing data ecosystems. Their investment strategy centers around identifying and backing European deep-tech teams that can become global hidden champions. They aim to build strategic relevance by positioning these companies for acquisition by larger, strategic buyers with access to international capital markets. eCAPITAL's investment approach emphasizes strategic support, providing access to an international network of entrepreneurs, scientists, investors, and founders. They also provide valuable contacts and extensive expertise, allowing them to challenge strategies, help refine business models, and bring in new ideas. They take an entrepreneurial approach, demonstrating a passion for bold ideas and new technologies, and aim to support founders in every pivotal moment.
node.vc
Node.vc is a sector-agnostic fund investing in early-stage Nordic companies driven by disruptive forces. They are particularly interested in companies reshaping the technological and social arenas, focusing on areas where they have high confidence in future growth. Their approach is based on the interconnectedness of technology with global trends, seeking innovative solutions across various sectors. They aim to back the next generation of visionaries, leveraging their experience as founders and operators to mitigate risks and guide startups through the challenges of building a company. They possess the collective knowledge required to identify promising ventures and assist potential unicorns in achieving significant growth.
10K Ventures
10K Ventures is a venture capital firm that invests its own capital and time in early-stage startups, funds, and businesses. They are inspired by relentless founders tackling big problems globally and are intellectually curious about massive opportunities driven by emerging technologies. Their investment strategy revolves around 100x ambition, aiming to turn $10-50k tickets into >$1Mn outcomes, focusing on bold and fast-moving companies from Day 0 to pre-seed with a clear path to >1Bn€ exits within 10 years. They prioritize business models that redefine and outperform the status quo, favoring innovative and scalable technologies with significant value creation potential. 10K Ventures emphasizes founders who can effectively sell their vision, execute flawlessly, and compound their successes over the long term. They seek founders with strong founder-market fit and the courage to pursue significant, long-term growth rather than optimizing for short-term gains. They aim to win deals through relevance and reputation, focusing on providing value-add to attract top founders. They build a strong network of investors, talent, and BD/partnerships to provide valuable introductions. They strive to maintain a good reputation for picking winners, avoiding a spray-and-pray approach, acting as superfans for founders and going the extra mile to provide support when needed. Their investment approach is multi-asset class, but their core focus is on venture-backed companies. They have a strong track record, with over 20 direct early-stage startup investments, achieving >6x TVPI and +46% IRR, including 6 soonicorns and a 9-figure exit. They have also invested in 4 early-stage funds spanning Emerging Markets and UK / Europe.
115K
115K, the Venture Capital fund of La Banque Postale, focuses on early-stage European companies within the financial services sector. They aim to blend the excellence of a standard VC team with the strength and reach of a large, diversified public group. Their investment strategy targets companies in the FinTech, AssurTech, Cybersecurity, Data, and AI spaces, supporting them from Seed to Series B stages. 115K seeks to reinvent the VC model by offering a unique combination of VC expertise and the resources of a major financial institution, La Banque Postale. They invest in companies based in France and the broader European Union.
2Ivc
2i Ventures, co-founded with Altshuler Shaham, invests in early-stage companies transforming both civilian and national security markets. They back bold founders solving big problems with innovations across a range of critical sectors. Their investment strategy focuses on dual-impact ventures, suggesting investments generate both financial returns and positive social or security outcomes. The firm leverages its experience in venture capital, entrepreneurship, and technology to partner with founders and other VCs, helping them translate innovative ideas into tangible results.
42 Cap
42CAP focuses on seed-stage tech- and data-driven B2B software companies across Europe with global ambition. The firm invests in businesses that leverage data and technology to create sustainable ventures. 42CAP's investment strategy is built upon the partners' experience as entrepreneurs who built two of Europe's largest software companies in the first internet wave, aiming to bring their entrepreneurial experience to support founders in the B2B software sector. They position themselves as peers amongst entrepreneurs.
8a + INVESTMENTS
8a+ Investments is an Italian asset management firm (SGR) founded in 2006 that focuses on creating value for investors, Italian businesses, and the local economy. They curate savings through a diverse range of financial instruments tailored to various investment needs. Since late 2019, they've expanded into Private Markets, offering innovative products that optimize deal selection. The firm invests in small and medium-sized Italian enterprises (SMEs), providing them with supplementary support alongside traditional credit. Their investment approach aims to actively support the country's entrepreneurial ecosystem, generating broader benefits for the region. They believe in responsible investing, ensuring adherence to social, environmental, and governance (ESG) standards, which they believe reduces risk and promotes stronger financial performance. Their recent innovative products include the 8a+ Sacro Monte fund, aligned with the social doctrine of the Catholic Church, and the 8a+ Real Innovation and 8a+ Real Italy ELTIF funds, which target higher returns through Private Markets investments. They focus on diversification and supporting Italian businesses by offering financial products that allow private investors to invest in the real economy, diversifying their portfolios while fostering the growth of Italian SMEs. Investing in SMEs offers an opportunity to contribute to their success and share in their progress over time. 8a+ Investments seeks to identify the best investment opportunities for both institutional and private clients, leveraging an experienced team that has worked together for over 15 years to support the long-term development of its portfolio companies.
ATOORO Fund
ATOORO Fund is an Israeli family venture fund that aims to support innovative entrepreneurs in building global companies. They focus on deep-technology ventures across several high-growth areas, including AI Models & Inference Computing, Physical AI & Robotics, Food Security, Bio-Mathematics, Quantum Computing, Computational Biology, and Clinical and Health Systems Platforms. The fund targets early and seed stages, providing initial investments typically ranging from $0.5 million to $5 million. They prefer to lead or co-lead the investment rounds they participate in, indicating an active role in guiding and supporting their portfolio companies. ATOORO's strategy involves identifying and investing in companies that are developing cutting-edge technologies within their focus areas. This includes companies involved in bioinformatics, food security (such as autonomous beehives and novel farming systems), quantum computing (quantum search and simulation), space commercialization (nanosatellites and space data services), synthetic biology (cellular agriculture and bioprinted organs), and perceptual computing (real-time 3D scanning and human-computer interaction). The diversity of these sectors demonstrates a broad interest in disruptive technologies. The fund's investment approach reflects a commitment to supporting early-stage companies with significant growth potential. By leading or co-leading rounds, ATOORO likely aims to take a more active role in providing strategic guidance, mentorship, and access to their network. As a family venture fund, it may also offer a long-term perspective and patient capital to nurture its investments over time. Overall, ATOORO's strategy revolves around identifying promising deep-tech ventures in Israel and globally, providing them with early-stage funding, and actively supporting their growth through strategic guidance and access to resources. Their focus on specific technology verticals and their preference for leading or co-leading rounds highlight their commitment to actively participating in the success of their portfolio companies.
Accurafy 4
Accurafy 4 is an alternative venture capital fund with a hands-on approach, focusing on early-stage tech companies in Europe. Their investment philosophy, encapsulated by the mantra "Invest For Good", emphasizes the compatibility of technology and sustainability. They seek to invest in tech companies driven by disruptive approaches and resilient management teams, with revenue traction and scalable models. They provide curated deals with a bespoke approach, risk & performance segregation, tax-efficient model, and aligned interests with their managers and senior advisors committing a minimum of 10% participation in each club deal. They aim for high performance returns by maintaining low management fees, allowing more than 94% of subscriptions to be invested in companies. Accurafy 4 actively supports companies from seed to large Series or IPO, with ticket sizes ranging from €500K to €5m. Their hands-on approach involves day-to-day support from Accurafy Advisory's team and a pool of Senior Advisors, tailored to the startup's needs. The firm leverages a thorough due diligence process while maintaining flexibility and efficiency. Furthermore, they provide access to a network of high-level investors who are successful entrepreneurs. Recently, Accurafy has partnered with Rémy Thannberger to create the "Fonds Souveraineté", a €100 million Pre-IPO investment vehicle dedicated to profitable, fast-growing French and European SMEs operating in the aerospace, defense, and security sectors. This fund aims to support critical industrial companies in their capital structuring and access to financial markets, without loss of control or excessive dilution. It adopts a hybrid approach, midway between private equity and capital markets, targeting companies aiming for a listing on the Euronext Growth compartment or on LISE - Lightning Stock Exchange. Accurafy's governance structure is built on four pillars: a General Partner (GP) founded by successful entrepreneurs, a club of qualified Investors (LPs), an LP/GP master agreement, and a senior advisory board. Accurafy 4 is an Alternative Investment Fund (AIF) under Luxembourg law constituted as a Special Limited Partnership Company (SCSp), administered with Grant Thornton Luxembourg and registered as an AIFM by the CSSF.
Aera
Aera VC is an early-stage venture capital fund focused on investing in companies that are building a more resilient future. The firm seeks to back companies that it believes can become future icons. Aera VC emphasizes a global reach and unique deal flow across the USA, APAC, and beyond, empowering founders to scale. The firm's management company is licensed and regulated as a VCFM by the Monetary Authority of Singapore. Aera VC invests in companies developing technologies and solutions that address critical global challenges, particularly in areas related to sustainability, resilience, and the future of industry. Their portfolio companies demonstrate a commitment to innovation and positive impact, suggesting a thesis centered around creating long-term value through investments in transformative technologies. The investment approach seems to be driven by a belief in the power of technology to solve pressing global issues and create a more sustainable world. Their portfolio highlights technologies in earth observation, space propulsion, AI grid optimization, carbon-negative data centers, sustainable chemicals, and sustainable aviation fuel.
Aglaia
Aglaia Oncology Funds invests in early-stage oncology drug development companies with breakthrough inventions that have the potential to transform cancer treatment. They focus on selecting and maturing these early-stage ventures, de-risking them and making them attractive candidates for licensing, acquisition, or IPO. Aglaia is committed to defining the strategic directions of the companies it invests in in close collaboration with innovators and entrepreneurs. Since 2004, Aglaia has built a reputation for starting up biotech companies focused on oncology drug development. They bring hands-on experience in designing research and development plans, ranging from early screening and animal feasibility studies through clinical studies. The Aglaia team has decades of experience in cancer research and oncology drug development. Aglaia's continuous strategic and operational involvement with portfolio companies has contributed to a marked success rate in transitioning early-stage portfolio companies to clinical-stage companies. Six of the 12 companies they've invested in were founded by Aglaia.